Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)

Cabio Biotech (Wuhan) Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,262	3,203	3,013	5,438	7,373	4,752
Market Cap Growth	70.46%	6.31%	-44.60%	-26.24%	55.15%	6.39%
Enterprise Value	4,119	3,077	2,760	4,910	6,676	3,922
Last Close Price	25.32	19.03	17.63	31.55	42.39	27.12
PE Ratio	29.03	25.79	32.97	84.48	57.34	36.39
Forward PE	27.75	22.89	23.21	32.26	-	-
PS Ratio	7.17	5.77	6.79	12.55	21.00	14.69
PB Ratio	2.65	2.04	2.02	3.82	5.34	3.59
P/TBV Ratio	2.74	2.12	2.10	3.93	5.39	3.65
P/FCF Ratio	-	-	-	-	-	42.13
P/OCF Ratio	26.22	18.51	43.73	30.83	71.38	32.57
EV/Sales Ratio	6.93	5.54	6.22	11.33	19.02	12.13
EV/EBITDA Ratio	22.55	19.57	22.42	54.31	53.40	28.89
EV/EBIT Ratio	32.81	29.89	36.28	76.29	65.65	35.73
EV/FCF Ratio	-119.57	-	-	-	-	34.78
Debt / Equity Ratio	0.03	0.01	0.01	0.02	0.00	-
Debt / EBITDA Ratio	0.29	0.12	0.10	0.36	0.02	-
Asset Turnover	0.35	0.34	0.28	0.28	0.25	0.24
Inventory Turnover	2.68	2.60	2.73	3.29	2.46	2.33
Quick Ratio	5.43	4.67	4.77	4.35	14.93	19.82
Current Ratio	7.46	6.45	6.31	5.03	16.59	21.47
Return on Equity (ROE)	9.01%	7.84%	5.92%	4.39%	9.71%	10.49%
Return on Assets (ROA)	4.68%	3.90%	2.95%	2.63%	4.49%	5.12%
Return on Capital (ROIC)	4.92%	4.16%	3.21%	2.83%	4.70%	5.33%
Return on Capital Employed (ROCE)	7.60%	6.50%	5.10%	4.50%	7.30%	8.20%
Earnings Yield	3.40%	3.88%	3.03%	1.18%	1.74%	2.75%
FCF Yield	-0.81%	-1.20%	-7.59%	-1.34%	-0.95%	2.37%
Dividend Yield	0.79%	1.05%	1.13%	0.68%	0.56%	0.87%
Payout Ratio	23.52%	27.38%	40.04%	61.90%	31.01%	45.95%
Buyback Yield / Dilution	3.92%	0.80%	0.11%	-0.69%	-0.31%	-32.80%
Total Shareholder Return	4.72%	1.85%	1.24%	-0.02%	0.25%	-31.93%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.